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SEROPREVALENCE OF ANTIBODIES TO VENEZUELAN EQUINE ENCEPHALITIS COMPLEX
(SUBTYPES IAB AND VI) IN HUMANS FROM GENERAL BELGRANO ISLAND, FORMOSA, ARGENTINA
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SUMMARY
This work presents the results of the detection of antibodies (immunoglobulin G) for subtypes I and VI of VEE viruses complex
(Togaviridae family) in people from the General Belgrano island, Formosa province (Argentina). The prevalence of neutralizing (NT)
antibodies for subtype VI was from 30% to 70% and the prevalence of antibodies inhibitory of hemagglutination (HI) was of 0% in
the first and second inquiry respectively. For the subtype IAB the prevalence of NT antibodies was from 13% to 3.6%, similar to the
prevalence total for both subtypes. HI antibodies were not detected in any inquiries for any subtype. It was observed that both
subtypes circulate simultaneously, while subtype VI remains constant with some peaks, subtype I was found in low level.
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INTRODUCTION
Venezuelan equine encephalitis viruses (VEEV) are arthropod-borne,
Western Hemisphere alphaviruses in the family Togaviridae. The VEE
antigenic complex currently consists of six subtypes (I- VI). Subtype I
is divided into five varieties (IAB, IC, ID, IE, IF), and subtype III is
divided into three varieties (IIIA, IIIB, IIIC) (CALISHER et al., 1985
and 1988). The first two varieties of subtype I (AB, C) are considered
epizootic and epidemic on the basis of epidemiological evidences and
experimental infections, being the other varieties (D, E and F) enzootic
and endemic (WORK, 1964; EHRENKRANZ & VENTURA, 1974).
VEE viruses produce infections in humans, which range from
indifferentiated acute febrile diseases to slight and serious encephalitis,
in less proportion (CALISHER, 1994). The varieties AB and C (subtype
I) were the agents in epizootic equine disease that occurred for almost
twenty years in Central and South America. Human cases were
sporadically informed.
In general, epizootic varieties cause serious disorders in medical
and veterinary conditions. Consequently it also causes economical and
labor detriments (CALISHER, 1994).
IVERSSON et al. (1990), informed about an outbreak of the disease
in humans in Ribeira Valley (São Paulo, Brazil), caused by subtype
enzootic I F. Between 1993 and 1995 VEEV produced the most serious
human infections in Colombia, Mexico and Venezuela, where enzootic
subtypes IC and ID were isolated with high mortality among infected
individuals. Simultaneously isolations and identifications in equines of
subtypes epizootics and enzootics IAB, IC, ID and IE, (RIVERA et al.,
1995) were described.
Recent equine outbreaks in southern Mexico with 40-50% case-
fatality rates yielded subtype IE strains (OBERSTE et al., 1998). The
close genetic relationship between the 1992-1993 IC viruses and enzootic
ID strains from the nearby Catatumbo region of northern South America
provides a model for the emergence of epidemic/epizootic VEE. In this
model, enzootic ID viruses undergo one or more critical mutations that
enhance equine viremia and virulence. The infrequency of epizootic VEE
emergence and the high mutation frequencies exhibited by RNA viruses,
including alphaviruses, suggest that an infrequent combination of several
mutation leads to emergence (WEAVER, 1998). This finding show an
epidemiological point of view, this behavior makes the separating line
among enzootic and epizootic subtypes less sharp.
In Argentina, BETTINOTTI (1957) made the first seroepidemiological
reports. He clearly demonstrated the activity of VEEV in Chaco and
Corrientes provinces, with a prevalence of 50%. In 1980, 19 strains of
subtype VI (enzootic) were isolated from mosquitoes collected in Chaco
province (MITCHELL et al., 1985). Later, antibodies to subtypes I AB
and VI were detected in birds, rodents and equines (MONATH, 1980).
The prevalence of antibodies against VEE-subtype IAB, strain TC-
83 and subtype VI was reported in patients with acute febrile outbreak
in 1989, at General Belgrano island of the Paraná river, Formosa province
(CONTIGIANI et al., 1993).
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This work presents the results of a seroprevalence study for VEE
subtypes IAB and VI on the population of the island General Belgrano
during 1991.
MATERIALS AND METHODS
Study area and human sera: The area of the Parana river of Formosa
province, Argentina, is covered with tropical rain forest with diverse
flora and fauna. Climatic conditions are mild, at the north-east of the
province is dry and the rest has 800 a 1000 mm precipitations per year.
Mean annual temperature is 22–24 ºC. There is one season with higher
temperature in December-January and lower in May-August.
Sera were collected from the General Belgrano little island (Fig. 1)
inhabitants obtained by the Servicio Provincial de Chagas during 1991.
Human main activity is farming which produces corn and citrus fruits.
Thirty families live in the island (population: 150).
The first sera samples were 23 in total, and were taken in May from
the school community where the 1989 outbreak took place. Fifteen
persons were between 4-16 year-old with an even gender distribution;
and 8 people were 24-50 year-old. All attended at the local school facility.
Two of these samples had been studied during the outbreak in 1989 and
were retested in 1991. The tendency distributions sexual near of 90%
toward female.
On the basis of the prevalence results obtained from the pilot test
carried out in this study, the size of the minimal sample was calculated
for an error of 10%, which was n = 33, using the methods described by
RAMIREZ et al., 1990.
Later, 33 samples were received from the second collection in
November 1991. This group had 19 individuals 3-20 year-old and 14
adults. None of them belonged to the previous study of May. The tendency
distributions sexual near of 70% toward female.
The sera were maintained at –20 ºC until they were tested.
Viral strains: Two viral strains of VEE complex were used:
- Strain TC-83: vaccine strain derived from Trinidad donkey (TRD
virus), subtype IAB, with 83 passages in guinea pig heart tissue
culture (BERGE et al., 1961).
- Strain AG 80-663: enzootic strain with low pathogenesis for equines
and unknown for humans, isolated from mosquito Culex
(Melanoconion) delpontei in Argentina, 1980 (CALISHER et al.,
1985).
Serological test: The detection and titration of specific antibodies
were carried out by Hemagglutination Inhibition Test (HI) (CLARKE
& CASALS, 1958) and Neutralization Test (NT) using a method of
quantification plaques forming units (EARLY et al., 1967).
The sera problem and normal mouse ascitic fluid (NMAF) for HI
were previously acetone extracted, to eliminate unspecific inhibitors and
then adsorbed by red blood cells of adults white domestic goose (Anser
cinereus) to remove the agglutinins. The NMAF were used as negative
controls and the hyperimmune mouse ascitic fluids (HMAF) obtained
for each strain were used as positive controls, according to TIKASINGH
et al. (1966).Viral antigens used for HI test, were prepared following
the methodology of CLARKE & CASALS (1958). Four-eight units were
used, at pH 6.3, for every antigen. Sera were considered positive from
dilutions 1:20.
For NT, Vero Cl 76 cell line was used, cultured in Minimum Essential
Medium (MEM) enriched with non essential aminoacids with 10% of
fetal calf serum (FCS) and gentamicine. Monolayers of 24-48h were
used in plastic trays of 12-24 wells and kept at 37 ºC in a 5% CO
2
atmosphere. The inoculum was prepared from brains of Swiss albino
mice infected with the strains involved in the study with 10% P/V in
(MEM) plus 10% of FCS and gentamicine. The brains were harvested
48 h post-infection, grinded and suspended 10% P/V in MEM, 10%
FCS and gentamicine. Sera were diluted at 1:5 in MEM and those that
neutralized the 80% the plaques forming units (pfu) included in the test
were considered positive.
RESULTS
The results of the antibody prevalence are presented in the Table 1.
The presence of both subtypes IAB and VI of the VEE complex was
observed in two surveys conducted.
Only five of the 23 sera collected in May were positive by HI for
both subtype, the other 18 were negative. Seven sera assayed by NT
were positive for subtypes VI, three sera for the subtypes IAB and three
sera had antibodies for both subtypes.
None of the 33 sera from the samples obtained in November wereFig. 1 - Map of General Belgrano Island, Formosa province, Argentina.
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positive by HI. However, by NT 23 were reactive for subtype VI, one for
subtype IAB and two for both.
Among the samples obtained in the two inquires, two sera negative
in the 1989 outbreak resulted positives in May (one for each subtype).
These samples belonged to a 10 year-old girl infected with subtype IAB
(title 1:64) and the other one to a 5 year-old boy with subtype VI (title
1:256).
DISCUSSION
BETINOTTI in 1957 made the first seroepidemiological studies on
the VEE viruses in humans of Argentina. MONATH (1980) reported
about the circulation of more than one subtype of the VEE complex in
the near zone to Chaco province among host as equines and rodents.
The NT test has the highest specificity for the detection of arbovirus
antibodies, and is considered the gold standard reference method
(CALISHER et al., 1980). Previous studies using the same test showed
that subtype IAB has no antigenic relationship with subtype VI
(CÁMARA, 1997).
The studies conducted in General Belgrano Island confirm the activity
of the subtypes I and VI of the VEE complex in humans; as a result there
are persons which were infected with only one subtype and others with
both. This finding in humans agrees with the results informed by
CONTIGIANI et al., 1993; although must be interpreted cautiously since
clinical observations were incomplete (SABATTINI et al., 1998).
According to our results, the prevalence of antibodies, during this
study was highest for the subtype VI (NT), while there were not detected
cases by HI for each subtype by separate, but only the prevalence by HI
for both subtypes together was observed. Although, there were few
common samples between the 1989 outbreak and May 1991 surveys,
two sera became positive, suggesting the circulation of both subtypes.
Subtype VI circulation and the higher prevalence for this virus in the
studied period suggests that the activity of this subtype presents with
peaks of higher presence, while was lower activity of subtype IAB, that
maintain cryptic or silent state.
The analysis of these results indicates that there is circulation of
both subtypes and that generating the best genetic conditions for the
recombination of strains, which may emerge as more aggressive or
virulent (epizootic or not) that would lead to new epidemics when better
biological conditions are given. This intrinsic behavior, from the genetic
point of view, could explain why the separation line between the enzootic
and epizootic subtypes results very indefinite, from an epidemiological
focus.
We must also consider the factor of the alterations of the ecosystem
that are produced naturally or those that are man-made as a result of
socioeconomic changes.
In this study we showed that the circulation of both subtypes of
VEE, but most importantly, new infections on the outside of outbreaks,
showing the need of maintaining continuous studies to know the behavior
of these subtypes in our area.
RESUMO
Estudo da soroprevalência de anticorpos para o vírus do
complexo encefalite equina venezuelana (EEV) (subtipos IAB e
VI) em humanos da Ilha General Belgrano, Formosa, Argentina
Este trabalho apresenta os resultados da detecção de anticorpos
(imunoglobulina G) para os subtipos I e VI dos vírus do complexo EEV
(Familia Togaviridae) em população da Ilha General Belgrano, província
de Formosa (Argentina). A prevalência de anticorpos neutralizantes para
o subtipo VI foi de 30% a 70% na primeira e segunda pesquisa
respectivamente, e por inibição de hemaglutinação (IH) de 0%. Para o
subtipo IAB, a prevalência foi de 13% a 3,6% por NT, enquanto
anticorpos IH não foram detectados nas duas pesquisas. Observou-se
que ambos subtipos circularam simultaneamente, mas enquanto o subtipo
VI manteve-se constante com alguns picos de maior presença, o subtipo
IAB foi encontrado em nível baixo.
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